Ubs Asset Management Americas Inc Vericel Corp Transaction History

Ubs Asset Management Americas Inc

  • $277 Billion
  • Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Vericel Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 55,226 shares of VCEL stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,226
Previous 52,602 4.99%
Holding current value
$2.49 Million
Previous $1.87 Million 53.34%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$32.52 - $52.33 $85,332 - $137,313
2,624 Added 4.99%
55,226 $2.87 Million
Q4 2023

Feb 14, 2024
BUY
$30.85 - $37.09 $47,169 - $56,710
1,529 Added 2.99%
52,602 $1.87 Million
Q3 2023

Nov 13, 2023
BUY
$31.69 - $39.25 $643,845 - $797,442
20,317 Added 66.06%
51,073 $1.71 Million
Q1 2023

May 15, 2023
SELL
$23.85 - $31.34 $12,354 - $16,234
-518 Reduced 1.66%
30,756 $901,000
Q2 2022

Aug 12, 2022
SELL
$22.88 - $39.45 $221,226 - $381,442
-9,669 Reduced 23.62%
31,274 $787,000
Q3 2021

Nov 15, 2021
SELL
$46.35 - $59.75 $3,059 - $3,943
-66 Reduced 0.16%
40,943 $2 Million
Q2 2021

Aug 16, 2021
BUY
$47.2 - $67.81 $490,502 - $704,681
10,392 Added 33.94%
41,009 $2.15 Million
Q1 2021

May 14, 2021
BUY
$30.93 - $59.48 $35,198 - $67,688
1,138 Added 3.86%
30,617 $1.7 Million
Q4 2020

Mar 01, 2021
SELL
$18.53 - $31.5 $163,064 - $277,200
-8,800 Reduced 22.99%
29,479 $910,000
Q3 2020

Nov 13, 2020
SELL
$14.68 - $19.12 $8,881 - $11,567
-605 Reduced 1.56%
38,279 $709,000
Q2 2020

Aug 14, 2020
SELL
$8.5 - $15.82 $90,414 - $168,277
-10,637 Reduced 21.48%
38,884 $537,000
Q1 2020

May 15, 2020
BUY
$7.25 - $19.22 $7,511 - $19,911
1,036 Added 2.14%
49,521 $454,000
Q4 2019

Feb 14, 2020
BUY
$13.77 - $19.2 $47,561 - $66,316
3,454 Added 7.67%
48,485 $843,000
Q3 2019

Nov 14, 2019
BUY
$14.93 - $19.83 $101,777 - $135,181
6,817 Added 17.84%
45,031 $681,000
Q2 2019

Aug 15, 2019
BUY
$15.01 - $18.89 $396,474 - $498,960
26,414 Added 223.85%
38,214 $0
Q4 2018

Feb 13, 2019
BUY
$10.77 - $18.44 $127,086 - $217,592
11,800 New
11,800 $205,000

Others Institutions Holding VCEL

# of Institutions
263
Shares Held
48.9M
Call Options Held
150K
Put Options Held
128K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.13B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email